Completed PHASE3 INTERVENTIONAL 2-arm NCT00269399

A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

A Double-Blind, Randomized, Controlled Trial of Rifaximin Compared to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Sponsor: Bausch Health Americas, Inc.

Conditions Clostridium Infections Diarrhea

Interventions Rifaximin (Xifaxan) Vancomycin

Updated 9 times since 2017 Last updated: Sep 30, 2019 Started: Dec 31, 2005 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00269399, this PHASE3 trial focuses on Clostridium Infections and Diarrhea and remains completed. Sponsored by Bausch Health Americas, Inc., it has been updated 9 times since 2005, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Nov 2019 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Jun 2019 — Nov 2019 [monthly]

Completed PHASE3
Jun 2018 — Jun 2019 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bausch Health Americas, Inc.

Data source: Bausch Health Americas, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Allentown, United States , Atlanta, United States , Baltimore, United States , Billings, United States , Boise, United States , Bristol, United States , Brooklyn, United States , Chevy Chase, United States , Chicago, United States , Cincinnati, United States and 46 more locations